Nicotine abuse either from tobacco cigarette or e-cigarette smoking is one of the most important risk factors in development of cardiovascular disease. Recent studies in women and animal models indicate that cigarette smoking or nicotine use by mothers during pregnancy increases the risk of hypertension and cardiovascular diseases in offspring. Oxidative stress has been implicated in the etiology of many diseases with substantial public health impact including chronic cardiovascular disorders and preeclampsia. Our recent studies in pregnant rats have demonstrated that perinatal nicotine exposure causes a development of vascular dysfunctional phenotype associated with an increased vascular specific NADPH oxidase (NOX2) gene expression and reactive oxygen species (ROS) production in adult offspring. However, the molecular mechanisms underlying nicotine-mediated programming of vascular oxidative stress are unclear. In addition, whether the heightened oxidative stress contributes to increase risk of vascular dysfunction in the adulthood remains undetermined. Thus, the proposed studies will test the central hypothesis that perinatal nicotine exposure epigenetically programs of NOX2 gene through DNA hypomethylation mechanism, resulting in increased vascular oxidative stress and development of vascular dysfunction phenotype in offspring. In this proposed study we will focus on two specific aims using a well-established pregnant rat model and offspring.
Aim 1 will determine whether perinatal nicotine causes CpG hypomethylation at specific transcription factor binding sites in NOX2 promoter, resulting in increased its promoter activity.
Aim 2 will determine whether treatment with methyl donor reverses nicotine-mediated hypomethylation and NOX over-expression. Furthermore, whether inhibition of NOX2 rescues nicotine-mediated excess ROS and reverses nicotine- mediated heightened vascular contractility and blood pressure response in offspring. The proposed studies will provide important and novel insights into the epigenetic mechanism of DNA methylation in up-regulation of NOX gene and NOX-derived ROS in vasculature. The outcomes will also provide novel evidence that fetal programming of vascular oxidative stress is the molecular mechanistic linker between nicotine and development of vascular dysfunction phenotype, which may lead to novel diagnostic tools and therapeutic approaches to prevent cardiovascular disease-induced by nicotine abuse in pregnancy.

Public Health Relevance

Epidemiological and animal studies suggest that maternal smoking/nicotine use during pregnancy increases oxidative stress in fetal, neonatal and adult tissues. This project will illustrate the epigenetic molecular mechanisms underlying prenatal nicotine exposure-induced fetal programming of vascular oxidative stress. We anticipate that the heightened oxidative stress will cause a development of hypertensive phenotype in adult offspring, and the expected outcomes will help to identify epigenetic mechanism and novel therapeutic target of cardiovascular diseases associated with adverse environmental exposure during pregnancy.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Research Grants (R03)
Project #
5R03DA041492-02
Application #
9458156
Study Section
Pregnancy and Neonatology Study Section (PN)
Program Officer
Bough, Kristopher J
Project Start
2017-05-01
Project End
2019-04-30
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Loma Linda University
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
009656273
City
Loma Linda
State
CA
Country
United States
Zip Code
92350